{"result": {"id": "b5c38760-fd1d-484c-80c8-7ae292b5d793", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"European Society of Hypertension and Associated Entities\",\n    \"summary\": \"The community is centered around the European Society of Hypertension (ESH), a pivotal organization in hypertension research and management. ESH collaborates with various professional societies, researchers, and organizations globally to develop and endorse hypertension guidelines, certify blood pressure monitoring devices, and advance hypertension care. Key entities include STRIDEBP, the International Society of Hypertension, and researchers like Poulter NR and Schlaich M, who contribute significantly to hypertension and cardiovascular research.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the community's significant role in shaping hypertension management practices and its extensive collaborations with leading medical societies and researchers.\",\n    \"findings\": [\n        {\n            \"summary\": \"ESH's central role in hypertension guidelines and device certification\",\n            \"explanation\": \"The European Society of Hypertension (ESH) is a cornerstone in the hypertension community, developing clinical guidelines and certifying blood pressure monitoring devices. Its collaborations with entities like STRIDEBP and the International Organization for Standardization ensure the accuracy and reliability of hypertension management tools. [Data: Entities (929, 932, 928); Relationships (773, 3756, 3757, +more)]\"\n        },\n        {\n            \"summary\": \"Global collaborations enhance hypertension management\",\n            \"explanation\": \"ESH's partnerships with the International Society of Hypertension and the World Hypertension League underscore its global influence in hypertension care. These collaborations facilitate the dissemination of evidence-based guidelines and initiatives like the May Measure Month project, aimed at improving hypertension detection and control worldwide. [Data: Entities (879, 880); Relationships (700, 702, +more)]\"\n        },\n        {\n            \"summary\": \"Key researchers driving hypertension and cardiovascular research\",\n            \"explanation\": \"Researchers such as Poulter NR and Schlaich M are instrumental in advancing hypertension and cardiovascular research. Their work spans clinical trials, preventive cardiology, and innovative treatments like renal sympathetic denervation for resistant hypertension, contributing to the community's knowledge base and treatment options. [Data: Entities (2494, 2895); Relationships (3135, 3046, +more)]\"\n        },\n        {\n            \"summary\": \"Importance of blood pressure monitoring standards\",\n            \"explanation\": \"The community emphasizes the standardization and certification of blood pressure monitoring devices, with entities like the International Organization for Standardization and STRIDEBP playing critical roles. These efforts ensure the reliability of hypertension diagnosis and management tools. [Data: Entities (928, 932); Relationships (769, 772, +more)]\"\n        },\n        {\n            \"summary\": \"Addressing hypertension in special populations\",\n            \"explanation\": \"The community focuses on managing hypertension in special populations, such as the elderly and those with endocrine disorders, through guidelines developed in collaboration with societies like the European Union Geriatric Medicine Society and the Chinese Society of Endocrinology. [Data: Entities (929, 3754); Relationships (3755, 3756, +more)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560525, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 640, "prompt_tokens": 6457, "total_tokens": 7097, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1664}, "prompt_cache_hit_tokens": 1664, "prompt_cache_miss_tokens": 4793}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n929,EUROPEAN SOCIETY OF HYPERTENSION,\"The **European Society of Hypertension (ESH)** is a professional organization dedicated to the study and management of hypertension and related conditions. It develops and publishes clinical guidelines, consensus statements, and position papers on various aspects of hypertension, including endocrine hypertension (e.g., primary aldosteronism) and blood pressure monitoring. ESH collaborates with other leading medical societies, such as the **European Society of Cardiology (ESC)**, to provide comprehensive treatment guidelines, and with the **European Union Geriatric Medicine Society (EUGMS)** to address hypertension management in very old and frail patients. Additionally, ESH plays a key role in certifying blood pressure monitoring devices, ensuring their accuracy and reliability in clinical practice. Through its multidisciplinary collaborations and evidence-based recommendations, ESH serves as a pivotal authority in advancing hypertension care across Europe and beyond.\",21\n932,STRIDEBP,\"Website that lists certified blood pressure monitoring devices\"\"\nSTRIDEBP is a website that lists certified blood pressure monitors\"\"\",5\n3771,WORKING GROUP ON ENDOCRINE HYPERTENSION,,2\n3773,ITALIAN SOCIETY OF ARTERIAL HYPERTENSION (SIIA),\"Professional society that published practical guidelines for managing primary aldosteronism\"\"\",2\n2364,STRIDE BP,\"STRIDE BP collaborated with the European Society of Hypertension on blood pressure monitoring guidelines\"\"\",1\n2383,EUROPEAN RENAL ASSOCIATION,\"An organization endorsing hypertension management guidelines\"\"\",1\n2392,MANCIAG,\"Researcher involved in the 2023 ESH hypertension guidelines\"\"\",1\n2393,KREUTZR,\"Researcher involved in the 2023 ESH hypertension guidelines\"\"\",1\n3754,CHINESE SOCIETY OF ENDOCRINOLOGY,\"The Chinese Society of Endocrinology is a professional organization that provides expert consensus on the diagnosis and treatment of primary aldosteronism and pheochromocytoma.\"\"\",1\n1366,ASCOT-LLA,The **ASCOT-LLA** (Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm) was the lipid-lowering component of the broader Anglo-Scandinavian Cardiac Outcomes Trial. This study investigated the benefits of combined blood pressure and lipid-lowering therapy in reducing cardiovascular risk. The findings from ASCOT-LLA contributed valuable evidence supporting the use of such combined therapeutic approaches in clinical practice.,2\n2604,JOURNAL OF HYPERTENSION,\"The **Journal of Hypertension** is a specialized academic publication dedicated to publishing research on hypertension. It focuses on advancing the understanding, diagnosis, and treatment of high blood pressure and related cardiovascular conditions. The journal serves as a key resource for researchers, clinicians, and healthcare professionals in the field of hypertension. Both descriptions emphasize its specialization in hypertension research, reinforcing its role as a leading source of scholarly work on the subject.\",3\n878,MAY MEASURE MONTH (MMM),\"An international project initiated by the International Society of Hypertension and the World Hypertension League to measure blood pressure, with China participating since 2017 and screening nearly 1.6 million adults\"\"\",4\n879,INTERNATIONAL SOCIETY OF HYPERTENSION,\"The **International Society of Hypertension (ISH)** is a global organization dedicated to addressing disparities in blood pressure control and improving hypertension management worldwide. It develops and endorses consensus statements and practice guidelines for hypertension, often collaborating with other leading organizations such as the **European Society of Hypertension**. The ISH also plays a key role in raising awareness about hypertension through initiatives like the **May Measure Month (MMM)** project, which it co-initiated to promote better detection and control of high blood pressure. Additionally, the organization provides evidence-based recommendations, including lifestyle management guidelines, to support healthcare professionals and patients in managing hypertension effectively. Through these efforts, the ISH strives to reduce the global burden of hypertension and improve cardiovascular health outcomes.\",10\n2492,SCHUTTE AE,Researcher involved in addressing global disparities in blood pressure control,1\n2493,JAFAR TH,Researcher involved in addressing global disparities in blood pressure control,1\n2610,CHARCHAR FJ,\"Author of International Society of Hypertension position paper\"\"\",1\n3840,VERDECCHIA P,A researcher involved in the 2020 International Society of Hypertension global hypertension practice guidelines,1\n3841,EUR J INTERN MED,\"A journal publishing research on internal medicine, including hypertension guidelines\",1\n2894,KRUM H,\"KRUM H is a researcher known for his involvement in studies related to renal sympathetic denervation as a treatment for resistant hypertension. He is one of the authors of a study focusing on catheter-based renal sympathetic denervation, specifically addressing its application in patients with resistant hypertension. His work contributes to the broader understanding of interventional therapies for managing this challenging condition.\",5\n2895,SCHLAICH M,\"**SCHLAICH M** is a researcher primarily focused on cardiovascular and metabolic disorders, with notable contributions to the study of **renal sympathetic denervation** as a treatment for **resistant hypertension**. He has been involved in multiple studies investigating this catheter-based therapeutic approach. Additionally, his research extends to related conditions such as **obesity and arterial hypertension**, indicating a broader interest in the interplay between metabolic and cardiovascular health. Schlaich M's work underscores his expertise in both clinical and investigative aspects of hypertension management.\",5\n2494,POULTER NR,\"**POULTER NR** is a researcher with a focus on cardiovascular health, hypertension, and global health disparities. His work includes studying the prevention of coronary and stroke events using atorvastatin in hypertensive patients, as well as contributing to the **TIME study**, which investigates optimal timing for hypertension treatment. Additionally, Poulter NR is engaged in research aimed at reducing global disparities in blood pressure control, highlighting his broader commitment to improving cardiovascular outcomes on an international scale. His multidisciplinary research spans clinical trials, preventive cardiology, and public health initiatives.\",6\n3004,ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL,\"A clinical trial studying cardiac outcomes with lipid-lowering treatments\"\"\",4\n927,HOME BLOOD PRESSURE MONITORING,\"HBPM is a method for patients to measure their blood pressure at home, offering data outside clinical environments and better correlation with organ damage\"\"\nA method for patients to measure blood pressure at home that correlates better with organ damage than clinic measurements\"\"\",5\n928,INTERNATIONAL STANDARDIZATION ORGANIZATION,\"ISO sets international standards for medical devices, including blood pressure monitors\"\"\",4\n933,INTERNATIONAL ORGANIZATION FOR STANDARDIZATION,\"International body that sets standards for medical devices including blood pressure monitors\"\"\",4\n2902,SYMPLICITY HTN-2,\"Symplicity HTN-2 is a multicentre safety and proof-of-principle cohort study on catheter-based renal sympathetic denervation for resistant hypertension\"\"\",4\n2994,DAHLÖF B,Dahlöf B is a researcher involved in studying the prevention of coronary and stroke events with atorvastatin in hypertensive patients,3\n2699,ROGERS A,\"Rogers A is a researcher involved in the TIME study on hypertension treatment timing.\"\"\",2\n2896,WHITBOURN R,\"Whitbourn R is a researcher who has contributed to studies on renal sympathetic denervation as a treatment for resistant hypertension. Specifically, Whitbourn R is recognized as one of the authors of a study investigating catheter-based renal sympathetic denervation for this condition. Their work focuses on advancing therapeutic approaches for managing resistant hypertension through innovative interventional techniques.\",3\n925,AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT,\"AOBP is a method for measuring blood pressure in a clinical setting, performed by patients themselves under standardized conditions\"\"\",3\n926,AMBULATORY BLOOD PRESSURE MONITORING,\"A method for monitoring blood pressure outside clinical settings that provides extensive data and better predicts cardiovascular risks\"\"\nABPM is a method for monitoring blood pressure outside of a clinical setting, providing extensive data and better predicting cardiovascular risks\"\"\",3\n2572,DURRER SCHUTZ D,\"A researcher involved in developing European guidelines for adult obesity management in primary care, published in Obesity Facts in 2019.\"\"\",3\n2573,WING RR,\"**WING RR** is a researcher who specializes in studying the benefits of weight loss, particularly for patients with type 2 diabetes. Their work has been published in an unspecified journal, focusing on how modest weight loss can positively impact health outcomes. The research underscores the importance of weight management in managing or mitigating type 2 diabetes.\",4\n2898,ESLER MD,\"**Esler MD** is a researcher and one of the authors involved in the **Symplicity HTN-2 trial**, a study focused on **renal sympathetic denervation** as a treatment for **resistant hypertension**. His work contributes to the investigation of this medical intervention for patients with high blood pressure that does not respond adequately to standard therapies.\",3\n930,BRITISH HYPERTENSION SOCIETY,\"BHS certifies blood pressure monitors according to international standards\"\"\nUK-based organization that certifies blood pressure monitors\"\"\",1\n931,ASSOCIATION FOR THE ADVANCEMENT OF MEDICAL INSTRUMENTATION,\"US-based organization that certifies medical devices including blood pressure monitors\"\"\nAAMI certifies medical devices, including blood pressure monitors\"\"\",1\n2993,SEVER PS,Sever PS is a researcher involved in studying the prevention of coronary and stroke events with atorvastatin in hypertensive patients,3\n3524,JORDAN J,Jordan J is a researcher or author associated with studies on obesity and arterial hypertension>,3\n3537,EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY,The European Association for the Study of Obesity is a professional organization that studies obesity and related conditions>,3\n881,CHINA HYPERTENSION LEAGUE,\"A Chinese organization that has been conducting the MMM project nationwide since 2017\"\"\",1\n880,WORLD HYPERTENSION LEAGUE,\"The **World Hypertension League (WHL)** is an organization dedicated to addressing hypertension globally. It actively endorses position papers on hypertension management, providing evidence-based guidelines and recommendations to improve patient care. Additionally, the WHL co-initiated the **May Measure Month (MMM)** project, an international campaign aimed at raising awareness about hypertension and improving its detection, treatment, and control. Through these initiatives, the WHL plays a pivotal role in advancing public health efforts to combat hypertension worldwide.\",3\n2490,STERGIOU G,Researcher involved in studies on bedtime dosing of antihypertensive medications,2\n2595,LANG W,\"A researcher who studied the benefits of modest weight loss, published in an unspecified journal.\"\"\",1\n2596,WADDEN TA,\"A researcher who studied the benefits of modest weight loss, published in an unspecified journal.\"\"\",1\n2698,MACKENZIE IS,\"Mackenzie IS is a researcher involved in the TIME study on hypertension treatment timing.\"\"\",3\n2897,SYMPLICITY HTN-2 INVESTIGATORS,\"The **SYMPLICITY HTN-2 INVESTIGATORS** are a group of researchers who conducted a randomized controlled trial focused on renal sympathetic denervation as a treatment for resistant hypertension. Their study, known as the Symplicity HTN-2 trial, investigated the efficacy and safety of this procedure in patients with hypertension that was difficult to control with standard therapies. The trial contributed to the understanding of renal denervation as a potential therapeutic approach for resistant hypertension.\",2\n3525,YUMUK V,Yumuk V is a researcher or author associated with studies on obesity and arterial hypertension>,2\n2593,BUSETTO L,\"A researcher involved in developing European guidelines for adult obesity management in primary care, published in Obesity Facts in 2019.\"\"\",1\n2594,DICKER D,\"A researcher involved in developing European guidelines for adult obesity management in primary care, published in Obesity Facts in 2019.\"\"\",1\n2394,BRUNSTRÖM M,\"BRUNSTRÖM M is a researcher primarily focused on the study of blood pressure and its clinical implications. Their work includes investigating the association between blood pressure lowering and outcomes such as mortality and cardiovascular disease. Additionally, BRUNSTRÖM M has contributed to the development of hypertension guidelines, notably participating in the 2023 ESH (European Society of Hypertension) guidelines. Their research underscores the importance of blood pressure management in reducing health risks and shaping evidence-based clinical recommendations.\",2\n2468,CARLBERG B,\"**CARLBERG B** is a researcher primarily focused on studies related to blood pressure, particularly its lowering effects and the association with mortality and cardiovascular disease. Their work explores the relationship between blood pressure management and health outcomes, including the potential impacts on mortality rates. The research contributes to a broader understanding of cardiovascular health and the implications of blood pressure modulation.\",1\n3764,ROSSI GP,\"Rossi GP is a researcher who contributed to the 2020 Italian Society of Arterial Hypertension guidelines for the management of primary aldosteronism.\"\"\",1\n3770,\"SCH(\"\"ENTITY\"\"\",,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n773,EUROPEAN SOCIETY OF HYPERTENSION,STRIDEBP,STRIDEBP lists devices certified by ESH,26\n3756,EUROPEAN SOCIETY OF HYPERTENSION,WORKING GROUP ON ENDOCRINE HYPERTENSION,The working group operates under the umbrella of the European Society of Hypertension,23\n3757,EUROPEAN SOCIETY OF HYPERTENSION,ITALIAN SOCIETY OF ARTERIAL HYPERTENSION (SIIA),Both organizations collaborate on hypertension research and guidelines,23\n2597,EUROPEAN SOCIETY OF HYPERTENSION,STRIDE BP,Collaborated on blood pressure monitoring guidelines,22\n2613,EUROPEAN SOCIETY OF HYPERTENSION,EUROPEAN RENAL ASSOCIATION,Both organizations endorsed the 2023 ESH guidelines for hypertension management,22\n2614,EUROPEAN SOCIETY OF HYPERTENSION,MANCIAG,ManciaG contributed to the 2023 ESH hypertension guidelines,22\n2615,EUROPEAN SOCIETY OF HYPERTENSION,KREUTZR,KreutzR contributed to the 2023 ESH hypertension guidelines,22\n3755,EUROPEAN SOCIETY OF HYPERTENSION,CHINESE SOCIETY OF ENDOCRINOLOGY,Both organizations provide guidelines and consensus statements on endocrine disorders,22\n1310,高血压患者,ASCOT-LLA,The ASCOT-LLA trial demonstrated cardiovascular benefits of lipid-lowering therapy in hypertensive patients,16\n2771,JOURNAL OF HYPERTENSION,WANG JG,Wang JG published hypertension risk research in this journal,16\n700,MAY MEASURE MONTH (MMM),INTERNATIONAL SOCIETY OF HYPERTENSION,The International Society of Hypertension co-initiated the MMM project,14\n2659,INTERNATIONAL SOCIETY OF HYPERTENSION,SCHUTTE AE,Schutte AE is a researcher involved in the International Society of Hypertension,11\n2660,INTERNATIONAL SOCIETY OF HYPERTENSION,JAFAR TH,Jafar TH is a researcher involved in the International Society of Hypertension,11\n2766,INTERNATIONAL SOCIETY OF HYPERTENSION,CHARCHAR FJ,Authored position papers for this organization,11\n3817,VERDECCHIA P,INTERNATIONAL SOCIETY OF HYPERTENSION,Verdecchia P contributed to the 2020 International Society of Hypertension guidelines,11\n3818,INTERNATIONAL SOCIETY OF HYPERTENSION,EUR J INTERN MED,The International Society of Hypertension guidelines were published in Eur J Intern Med,11\n3046,KRUM H,SCHLAICH M,Krum H and Schlaich M are co-authors of the study on renal sympathetic denervation,10\n3135,POULTER NR,ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL,Poulter NR was involved in the Anglo-Scandinavian Cardiac Outcomes Trial,10\n769,HOME BLOOD PRESSURE MONITORING,INTERNATIONAL STANDARDIZATION ORGANIZATION,HBPM devices are certified by ISO among other organizations,9\n772,INTERNATIONAL STANDARDIZATION ORGANIZATION,STRIDEBP,STRIDEBP lists devices certified by ISO,9\n776,STRIDEBP,INTERNATIONAL ORGANIZATION FOR STANDARDIZATION,STRIDEBP lists devices certified by ISO,9\n3048,KRUM H,SYMPLICITY HTN-2,Krum H is an investigator in the Symplicity HTN-2 study,9\n3133,DAHLÖF B,POULTER NR,Dahlöf B and Poulter NR collaborated on research about the prevention of coronary and stroke events with atorvastatin in hypertensive patients,9\n2841,ROGERS A,POULTER NR,Both researchers collaborated on the TIME study on hypertension treatment timing.,8\n3049,SCHLAICH M,WHITBOURN R,Schlaich M and Whitbourn R are co-authors of the study on renal sympathetic denervation,8\n763,AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT,INTERNATIONAL STANDARDIZATION ORGANIZATION,AOBP devices are certified by ISO among other organizations,7\n764,AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT,INTERNATIONAL ORGANIZATION FOR STANDARDIZATION,AOBP devices must meet ISO standards,7\n766,AMBULATORY BLOOD PRESSURE MONITORING,INTERNATIONAL STANDARDIZATION ORGANIZATION,ABPM devices are certified by ISO among other organizations,7\n2760,DURRER SCHUTZ D,WING RR,Both researchers contributed to guidelines or studies on weight management,7\n3051,WHITBOURN R,SYMPLICITY HTN-2,Whitbourn R is an investigator in the Symplicity HTN-2 study,7\n3053,ESLER MD,SYMPLICITY HTN-2,Esler MD is an investigator in the Symplicity HTN-2 study,7\n774,BRITISH HYPERTENSION SOCIETY,STRIDEBP,STRIDEBP lists devices certified by BHS,6\n775,ASSOCIATION FOR THE ADVANCEMENT OF MEDICAL INSTRUMENTATION,STRIDEBP,STRIDEBP lists devices certified by AAMI,6\n3130,SEVER PS,DAHLÖF B,Sever PS and Dahlöf B collaborated on research about the prevention of coronary and stroke events with atorvastatin in hypertensive patients,6\n3145,ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL,ASCOT-LLA,ASCOT-LLA was part of the Anglo-Scandinavian Cardiac Outcomes Trial,6\n3571,JORDAN J,EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY,Jordan J is associated with a joint statement by the European Association for the Study of Obesity,6\n702,MAY MEASURE MONTH (MMM),CHINA HYPERTENSION LEAGUE,The China Hypertension League has been conducting the MMM project in China since 2017,5\n2671,WORLD HYPERTENSION LEAGUE,STERGIOU G,Stergiou G is a researcher involved in the World Hypertension League,5\n2763,WING RR,LANG W,Lang W collaborated with Wing RR on the modest weight loss study,5\n2764,WING RR,WADDEN TA,Wadden TA collaborated with Wing RR on the modest weight loss study,5\n2838,MACKENZIE IS,ROGERS A,Both researchers collaborated on the TIME study on hypertension treatment timing.,5\n3052,SYMPLICITY HTN-2 INVESTIGATORS,ESLER MD,Esler MD is part of the Symplicity HTN-2 Investigators group,5\n3574,YUMUK V,EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY,Yumuk V is associated with a joint statement by the European Association for the Study of Obesity,5\n2761,DURRER SCHUTZ D,BUSETTO L,Busetto L collaborated with Durrer Schutz D on the European obesity guidelines,4\n2762,DURRER SCHUTZ D,DICKER D,Dicker D collaborated with Durrer Schutz D on the European obesity guidelines,4\n2652,BRUNSTRÖM M,CARLBERG B,Co-authors of a blood pressure mortality study,3\n3760,ROSSI GP,ITALIAN SOCIETY OF ARTERIAL HYPERTENSION (SIIA),Rossi GP contributed to the SIIA's practical guidelines for primary aldosteronism,3\n3762,\"SCH(\"\"ENTITY\"\"\",WORKING GROUP ON ENDOCRINE HYPERTENSION,ORGANIZATION,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_8d13d1b2a61ac8d0a5d87861ef54e73914618ce3f059b6526a13f8862b604de8_v2"}